Scholars Central

EditorialPublished 30 Mar 2021

Bioequivalence and its evaluation

Authors: Macroni Laco

Journal of Bioequivalence & Bioavailability

Volume 13 · Issue 2 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

On the off chance that two medications are supposed to be bioequivalent if there is no clinically critical contrast in their bioavailability. Bio equivalency testing includes correlation of proportions of bioavailability of the nonexclusive and trailblazer details. For drug reciprocals to be bioequivalent, "the rate and degree of ingestion of the test drug should not show a critical distinction between the rate and degree of retention of the reference drug when regulated at similar molar portion of the remedial fixings under comparable trial conditions as either a solitary portion or different dosages

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Macroni Laco”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels